{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:13:53Z","timestamp":1780496033159,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128338","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:30:22Z","timestamp":1771497022000},"page":"128338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Science for vaccine policy: Lack of transparency, misinformation, and poor decision processes at the December 2025 ACIP meeting"],"prefix":"10.1016","volume":"76","author":[{"given":"Jamie","family":"Loehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J.","family":"Asturias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hawkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Keipp","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel T.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128338_bb0005","series-title":"Third Kentucky Infant Dies of Pertussis; Disease Rates Elevated Nationwide","volume":"25","author":"Jenco","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128338_bb0010","author":"Canada PHA of. Statement from the Public Health Agency of Canada"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128338_bb0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jama.2025.10776","article-title":"Advisory committee on immunization practices at a crossroads","volume":"334","author":"Asturias","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128338_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMsb2509134","article-title":"The path forward for vaccine policy in the United States","volume":"393","author":"Chu","year":"2025","journal-title":"N Engl J Med"},{"issue":"6753","key":"10.1016\/j.vaccine.2026.128338_bb0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.adz8347","article-title":"Wadman M.The Members of RFK Jr.\u2019s new vaccine committee have published little on vaccines","volume":"388","author":"Enserink","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128338_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127876","article-title":"Science for vaccine policy: independent review of the September 2025 ACIP processes, deliberations and votes","volume":"67","author":"Asturias","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128338_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag042","article-title":"The erosion of a pillar of public health: ACIP\u2019s role and the future of U.S. vaccine policy post-June 2025","author":"Asturias","year":"2026","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2026.128338_bb0040","article-title":"Statement on vaccine coverage","author":"AHIP","year":"2025","journal-title":"AHIP"},{"key":"10.1016\/j.vaccine.2026.128338_bb0045","series-title":"Updated AAP lawsuit seeks to replace ACIP members, addresses harms of new COVID vaccine policy","volume":"5","author":"Jenco","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128338_bb0050","author":"Mandavilli"},{"key":"10.1016\/j.vaccine.2026.128338_bb0055","author":"National Academies"},{"key":"10.1016\/j.vaccine.2026.128338_bb0060","unstructured":"Raney V. 2027 Updates to the child and adult Core health care quality measurement sets and mandatory reporting guidance. Accessed December 10, 2025. https:\/\/www.medicaid.gov\/federal-policy-guiance\/2025-12-30\/187741."},{"issue":"24","key":"10.1016\/j.vaccine.2026.128338_bb0065","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2502567","article-title":"Disappearing data at the US federal government","volume":"392","author":"Freilich","year":"2025","journal-title":"N Engl J Med"},{"issue":"10500","key":"10.1016\/j.vaccine.2026.128338_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(25)01249-8","article-title":"Data manipulation within the US federal government","volume":"406","author":"Freilich","year":"2025","journal-title":"Lancet Lond Engl"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128338_bb0075","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.2025.5723","article-title":"Unreliable vaccine information and the erosion of science","volume":"333","author":"Jacobs","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128338_bb0080","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7440a1","article-title":"Effectiveness of 2024\u20132025 COVID-19 vaccines in children in the United States \u2014 VISION, august 29, 2024\u2013September 2, 2025","volume":"74","author":"Irving","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128338_bb0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2501622","article-title":"The consequences of silencing the \u201cVoice of CDC.\u201d","volume":"393","author":"Rasmussen","year":"2025","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128338_bb0090","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated evidence for Covid-19, RSV, and influenza vaccines for 2025\u20132026","volume":"393","author":"Scott","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128338_bb0095","first-page":"138","article-title":"An analytic framework for open meetings and transparency","volume":"15","author":"Piotrowski","year":"2010","journal-title":"Adm Manag"},{"key":"10.1016\/j.vaccine.2026.128338_bb0100","series-title":"December Meeting of the Advisory Committee on Immunization Practices (ACIP)","author":"Debunk Briefing","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128338_bb0105","author":"Regulations.gov"},{"key":"10.1016\/j.vaccine.2026.128338_bb0110","author":"CFR Part 1012"},{"key":"10.1016\/j.vaccine.2026.128338_bb0115","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128338_bb0120","series-title":"Vaccination at Birth: Safety, Effectiveness, and Public Health Impact","author":"Universal Hepatitis B","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128338_bb0125","unstructured":"Pregnancy Screening 2023. October 25, 2024. Accessed December 10, 2025. https:\/\/en.ssi.dk\/surveillance-and-preparedness\/surveillance-in-denmark\/annual-reports-on-disease-incidence\/p\/pregnancy-screening-2023."},{"issue":"5","key":"10.1016\/j.vaccine.2026.128338_bb0130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.1840010502","article-title":"A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): a final report","volume":"1","author":"Szmuness","year":"1981","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.vaccine.2026.128338_bb0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128338_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/01.inf.0000130953.08946.d0","article-title":"Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the Vaccine Safety Datalink project","volume":"23","author":"Eriksen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128338_bb0145","unstructured":"Adams S. Although public overwhelmingly supports Hepatitis B vaccine for a newborn, Partisan Differences Exist The Annenberg Public Policy Center of the University of Pennsylvania December 5, 2025. Accessed February 1, 2026. https:\/\/www.annenbergpublicpolicycenter.org\/although-public-overwhelmingly-supports-hepatitis-b-vaccine-for-a-newborn-partisan-differences-exist\/."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128338_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017 - recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128338_bb0155","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19\u201359 years: Updated recommendations of the advisory committee on immunization practices \u2014 United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128338_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.89.2.269","article-title":"Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees","volume":"89","author":"Hurie","year":"1992","journal-title":"Pediatrics"},{"issue":"19","key":"10.1016\/j.vaccine.2026.128338_bb0165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM198911093211905","article-title":"Hepatitis B virus infection among children born in the United States to southeast Asian refugees","volume":"321","author":"Franks","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.20006","article-title":"Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination","volume":"39","author":"Chen","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2026.128338_bb0175","series-title":"Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals - Gastroenterology","author":"AGA","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128338_bb0180","unstructured":"Why We Give Hepatitis B Vaccines to Infants. https:\/\/www.nfid.org\/. Accessed December 10, 2025. https:\/\/www.nfid.org\/why-we-give-hepatitis-b-vaccines-to-infants\/."},{"issue":"24","key":"10.1016\/j.vaccine.2026.128338_bb0185","first-page":"317","article-title":"Recommendation of the immunization practices advisory committee (ACIP). Inactivated hepatitis B virus vaccine","volume":"31","author":"Centers for Disease Control (CDC)","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-2","key":"10.1016\/j.vaccine.2026.128338_bb0190","first-page":"1","article-title":"Protection against viral hepatitis. Recommendations of the immunization practices advisory committee (ACIP)","volume":"39","year":"1990","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128338_bb0195","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1001\/jama.1991.03470200064036","article-title":"Hepatitis B prevalence in an unregistered prenatal population. Implications for neonatal therapy","volume":"266","author":"Silverman","year":"1991","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for Hepatitis B virus infection: CDC recommendations \u2014 United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10900-017-0388-6","article-title":"Sub-optimal testing and awareness of HCV and HBV among high risk individuals at an underserved safety-net hospital","volume":"43","author":"Wong","year":"2018","journal-title":"J Community Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0210","first-page":"188","article-title":"Gaps in viral hepatitis awareness in the United States in a population-based study","volume":"18","author":"Zhou","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.vaccine.2026.128338_bb0215","series-title":"Virus Screening and Management for Patients with Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update - PMC","author":"Hepatitis","year":"2025"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128338_bb0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/infdis\/jiy620","article-title":"High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides","volume":"219","author":"Than","year":"2019","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128338_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/jech.39.2.123","article-title":"Hepatitis B infection in households of acute cases","volume":"39","author":"Goh","year":"1985","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"10.1016\/j.vaccine.2026.128338_bb0235","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2012.12.012","article-title":"Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review","volume":"31","author":"Schillie","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128338_bb0240","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2026.128338_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1031924","article-title":"The adaptive immune system in early life: The shift makes it count","volume":"13","author":"Pieren","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128338_bb0250","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/hv.24844","article-title":"Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand","volume":"9","author":"Poovorawan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128338_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058029","article-title":"Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: No need for a booster dose","volume":"8","author":"Mendy","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after Hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128338_bb0265","first-page":"39","article-title":"Overview of clinical studies with hepatitis B vaccine made by recombinant DNA","volume":"13","author":"Zajac","year":"1986","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2026.128338_bb0270","unstructured":"Encephalitis | National Institute of Neurological Disorders and Stroke. Accessed December 11, 2025. https:\/\/www.ninds.nih.gov\/health-information\/disorders\/encephalitis."},{"issue":"3A","key":"10.1016\/j.vaccine.2026.128338_bb0275","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine","volume":"87","author":"Andr\u00e9","year":"1989","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: How it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128338_bb0285","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27577","article-title":"Association of number of doses with hepatitis B vaccine series completion in US adults","volume":"3","author":"Bruxvoort","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128338_bb0290","unstructured":"Group S. New analysis shows delaying the Hepatitis B birth dose may Lead to thousands of preventable infections and hundreds of millions in avoidable healthcare costs. HepVu December 1, 2025. Accessed January 27, 2026. https:\/\/hepvu.org\/news-updates\/new-analysis-shows-delaying-the-hepatitis-b-birth-dose-may-lead-to-thousands-of-preventable-infections-and-hundreds-of-millions-in-avoidable-healthcare-costs\/."},{"key":"10.1016\/j.vaccine.2026.128338_bb0295","article-title":"Universal hepatitis B vaccination at birth-risks of revising the recommendation","author":"Abers","year":"2025","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128338_bb0300","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.vaccine.2018.03.028","article-title":"Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis","volume":"36","author":"Klinger","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128338_bb0305","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128338_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01327-2","article-title":"Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers","author":"Pan","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128338_bb0315","doi-asserted-by":"crossref","DOI":"10.1177\/00333549231175548","article-title":"Progress and unfinished business: Hepatitis B in the United States, 1980\u20132019","author":"Bixler","year":"2023","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2026.128338_bb0320","unstructured":"WHO Position paper on Hepatitis B vaccines. Accessed December 11, 2025. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/7c11752b-43be-40ba-b665-17e17d75e731\/content."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128338_bb0325","article-title":"The WHO-INTEGRATE evidence to decision framework version 1.0: Integrating WHO norms and values and a complexity perspective","volume":"4","author":"Rehfuess","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128338_bb0330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bdm.503","article-title":"Comparing holistic and disaggregated ratings in the evaluation of scientific presentations","volume":"19","author":"Arkes","year":"2006","journal-title":"J Behav Decis Mak"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128338_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1467-9280.01410","article-title":"The nonuse of psychological research at two federal agencies","volume":"14","author":"Arkes","year":"2003","journal-title":"Psychol Sci"},{"key":"10.1016\/j.vaccine.2026.128338_bb0340","unstructured":"ACIP Charter Accessed December 10. 2025. https:\/\/www-cdc-gov\/acip\/downloads\/Policies-Procedures-508.pdf."},{"key":"10.1016\/j.vaccine.2026.128338_bb0355","unstructured":"FACA-Statute -2013.pdf. Accessed December 11, 2025. https:\/\/www.gsa.gov\/system\/files\/FACA-Statute-2013.pdf."},{"key":"10.1016\/j.vaccine.2026.128338_bb0345","doi-asserted-by":"crossref","unstructured":"Kreimer AR, Porras C, Liu D, et al. Noninferiority of one HPV vaccine dose to two doses. N Engl J Med 0(0). doi:https:\/\/doi.org\/10.1056\/NEJMoa2506765.","DOI":"10.1056\/NEJMoa2506765"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128338_bb0350","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1016\/j.vaccine.2022.06.065","article-title":"Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs","volume":"40","author":"Markowitz","year":"2022","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:45:39Z","timestamp":1775195139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":71,"alternative-id":["S0264410X26001465"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128338","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Science for vaccine policy: Lack of transparency, misinformation, and poor decision processes at the December 2025 ACIP meeting","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128338"}}